Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury

NCT00112164 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00112164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00112164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2005
Completion date
February 28, 2007
Enrollment
90 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult